These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36069904)

  • 21.
    Willsey GG; Eckstrom K; LaBauve AE; Hinkel LA; Schutz K; Meagher RJ; LiPuma JJ; Wargo MJ
    J Bacteriol; 2019 Aug; 201(15):. PubMed ID: 31109991
    [No Abstract]   [Full Text] [Related]  

  • 22. Cystic Fibrosis-Associated Stenotrophomonas maltophilia Strain-Specific Adaptations and Responses to pH.
    Gallagher T; Phan J; Oliver A; Chase AB; England WE; Wandro S; Hendrickson C; Riedel SF; Whiteson K
    J Bacteriol; 2019 Apr; 201(7):. PubMed ID: 30642989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection.
    Govan JR; Brown AR; Jones AM
    Future Microbiol; 2007 Apr; 2(2):153-64. PubMed ID: 17661652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative genomics of clinical
    McDaniel MS; Sumpter NA; Lindgren NR; Billiot CE; Swords WE
    Microbiology (Reading); 2023 Nov; 169(11):. PubMed ID: 37942787
    [No Abstract]   [Full Text] [Related]  

  • 25. Microbiology of Cystic Fibrosis Airway Disease.
    Blanchard AC; Waters VJ
    Semin Respir Crit Care Med; 2019 Dec; 40(6):727-736. PubMed ID: 31887768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis.
    Salsgiver EL; Fink AK; Knapp EA; LiPuma JJ; Olivier KN; Marshall BC; Saiman L
    Chest; 2016 Feb; 149(2):390-400. PubMed ID: 26203598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of respiratory tract infections on the nutritional state of children with cystic fibrosis.
    Trandafir LM; Moscalu M; Diaconu G; Cîrdeiu E; Tudose AA; Coman G; Păduraru DT
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(4):863-9. PubMed ID: 24502062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation.
    Lobo LJ; Tulu Z; Aris RM; Noone PG
    Transplantation; 2015 Oct; 99(10):2196-202. PubMed ID: 25856407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.
    Aanæs K
    J Cyst Fibros; 2013 Sep; 12 Suppl 2():S1-20. PubMed ID: 24064077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis.
    Murray TS; Stanley G; Koff JL
    Clin Chest Med; 2022 Dec; 43(4):667-676. PubMed ID: 36344073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis.
    Ulrich M; Beer I; Braitmaier P; Dierkes M; Kummer F; Krismer B; Schumacher U; Gräpler-Mainka U; Riethmüller J; Jensen PØ; Bjarnsholt T; Høiby N; Bellon G; Döring G
    Thorax; 2010 Nov; 65(11):978-84. PubMed ID: 20880875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbial Epidemiology of the Cystic Fibrosis Airways: Past, Present, and Future.
    Thornton CS; Parkins MD
    Semin Respir Crit Care Med; 2023 Apr; 44(2):269-286. PubMed ID: 36623820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients.
    Waters V; Atenafu EG; Lu A; Yau Y; Tullis E; Ratjen F
    J Cyst Fibros; 2013 Sep; 12(5):482-6. PubMed ID: 23294530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.
    Amin R; Jahnke N; Waters V
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009249. PubMed ID: 32189337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.
    Amin R; Waters V
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD009249. PubMed ID: 27415821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.
    Amin R; Waters V
    Cochrane Database Syst Rev; 2014 Apr; (4):CD009249. PubMed ID: 24696136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.
    Amin R; Waters V
    Cochrane Database Syst Rev; 2012 May; (5):CD009249. PubMed ID: 22592739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis.
    Murray TS; Stanley G; Koff JL
    Infect Dis Clin North Am; 2024 Mar; 38(1):149-162. PubMed ID: 38280761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism and Pathogenicity of Pseudomonas aeruginosa Infections in the Lungs of Individuals with Cystic Fibrosis.
    Palmer GC; Whiteley M
    Microbiol Spectr; 2015 Aug; 3(4):. PubMed ID: 26350318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cystic fibrosis related diabetes is not independently associated with increased Stenotrophomonas maltophilia infection: Longitudinal data from the UK CF Registry.
    Frost F; Nazareth D; Shaw M; Walshaw MJ
    J Cyst Fibros; 2019 Mar; 18(2):294-298. PubMed ID: 30741162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.